Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study
Fontana, Robert J., Lens, Sabela, McPherson, Stuart, Elkhashab, Magdy, Ankoma-Sey, Victor, Bondin, Mark, dos Santos, Ana Gabriela Pires, Xue, Zhenyi, Trinh, Roger, Porcalla, Ariel, Zeuzem, StefanJournal:
Advances in Therapy
DOI:
10.1007/s12325-019-01123-0
Date:
October, 2019
Fichier:
PDF, 520 KB
2019
File converter
Plus de résultats de recherche
More benefits 
